Conduit Pharmaceuticals Ownership | Who Owns Conduit Pharmaceuticals?


OverviewRevenueFinancialsChart

Conduit Pharmaceuticals Ownership Summary


Conduit Pharmaceuticals is owned by 0.30% institutional investors, and 99.70% retail investors. Karpus Conservative Balanced is the top mutual fund, with 2.31% of its assets in Conduit Pharmaceuticals shares.

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20231-94.12%198,925-87.42%-5.26%--100.00%1-80.00%
Jun 30, 202317-1,581,480-25.30%223.34%5-37.50%5-44.44%
Mar 31, 202317-55.26%2,117,044-80.74%31.16%8-50.00%9125.00%
Dec 31, 20223840.74%10,992,6323.97%166.50%1660.00%4300.00%
Sep 30, 20222712.50%10,573,3309.88%157.55%10-58.33%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Karpus Conservative Balanced144.10K2.31%-700.00
Karpus Tax Sensitive Fixed Income129.28K2.07%-9.25K
Karpus Taxable Fixed Income47.70K0.76%-700.00
Karpus Growth Balanced4.88K0.08%-

Insider Transactions Trends


DateBuySell
2023 Q1--

MURF Ownership FAQ


Does Blackrock own Conduit Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Conduit Pharmaceuticals.

Who is the top mutual fund holder of Conduit Pharmaceuticals shares?

Karpus Conservative Balanced is the top mutual fund holder of Conduit Pharmaceuticals shares, with 2.31% of its total shares outstanding invested in 144.1K Conduit Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools